Shield Therapeutics Plc (STX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2015 | 12-2014 | |
| Operating Expenses | 9,532 | 5,278 |
| Operating Income | -9,532 | -5,278 |
| Interest Expense | 2,764 | 2,576 |
| Other Income | -23,983 | -13,049 |
| Pre-tax Income | -36,279 | -20,903 |
| Net Income Continuous | -36,279 | -20,903 |
| Minority Interests | 1,276 | 817 |
| Net Income | $-35,003 | $-20,086 |
| EPS Basic Total Ops | -0.82 | -0.60 |
| EPS Basic Continuous Ops | -0.82 | -0.60 |
| EPS Diluted Total Ops | -0.82 | -0.60 |
| EPS Diluted Continuous Ops | -0.82 | -0.60 |
| EBITDA(a) | $-33,440 | $-18,271 |